Cesarean delivery and metabolic risk factors in young adults: a Brazilian birth cohort study

Juliana Rombaldi Bernardi1, Tanara Vogel Pinheiro2, Noel Theodore Mueller3

  • 1Biological and Health Sciences Center, University of Caxias do Sul, Caxias do Sul, Brazil; Department of Pediatrics, Porto Alegre Clinical Hospital, Faculty of Medicine, University of Rio Grande do Sul, Porto Alegre, Brazil;

Insights

Cesarean delivery is linked to higher body mass index (BMI) in young adults, but not other metabolic risks. This study examined the long-term health impacts of delivery method on metabolic health.

Area of Science:

  • Public Health
  • Epidemiology
  • Metabolic Health

Background:

  • Cesarean delivery (CD) impacts infant gut microbiome and is linked to obesity.
  • The association between CD and metabolic risk factors in young adults remains unclear.

Purpose of the Study:

  • To investigate the association between Cesarean delivery (CD) and metabolic risk factors in young adults.
  • To analyze long-term health outcomes related to delivery method.

Main Methods:

  • A cohort study in Brazil followed 2063 subjects for 23-25 years.
  • Data included delivery type, birth weight, maternal factors, and adult anthropometric and biochemical measurements.
  • Linear regression controlled for confounders to assess CD's association with metabolic factors.

Main Results:

  • Cesarean delivery (32.0%) was associated with higher body mass index (BMI) in young adults (23-25 years).
  • No significant association was found between CD and glucose, insulin resistance, or lipid profiles.
  • CD was more common in older and more educated mothers.

Conclusions:

  • Cesarean delivery is associated with increased BMI in young adulthood.
  • CD does not appear to be linked to other key metabolic risk factors like insulin resistance or dyslipidemia in this population.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.7K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
39
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
399
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.5K